New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Danimer Scientific, Inc.
DNMR
Shape
US Flag

NYSE

Unprofitable

EPS improving

Unprofitable

EPS improving

50M

Chemicals - Specialty

Next Earning date - 12 Nov 2024

50M

Chemicals - Specialty

Next Earning date - 12 Nov 2024

0.42USD
Shape0.00 ( 0.36%)
favorite-chart

Relative Strenght

1
favorite-chart

Volume Buzz

-54%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

77%

Quote Panel

Shape
Updated October 12, 2024
1W -10.34 % 1M 5.65 % 3M -32.28 % 1Y -74.86 %

Key Metrics

Shape
  • Market Cap

    50.40M


  • Shares Outstanding

    120.77M


  • Share in Float

    108.90M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.4173


  • Average Volume

    695501


  • Beta

    1.583


  • Range

    0.285-1.84


  • Industry

    Chemicals - Specialty


  • Website

    https://www.danimerscientific.com


  • Sector

    Basic Materials


Fundamentals

Shape

N/A

P/E Ratio

1.26x

P/S Ratio

0.21x

P/B Ratio

1.7

Debt/Equity

-325.9%

Net Margin

$-1.2

EPS

How DNMR compares to sector?

P/E Ratio

Relative Strength

Shape

DNMR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$91M

Shape1095%

2025-Revenue

$0.47

Shape-146%

2025-EPS

$59M

Shape-423%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

downgrade

Previous: Buy

2024-08-12

Now: Hold

Jefferies

downgrade

Previous: Not converted

2024-05-22

Now: Hold

Piper Sandler

downgrade

Previous: Not converted

2024-04-08

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.30
vs -0.09

Q4.22

arrow
arrow

N/A

-0.28
vs -0.29

Q1.23

arrow
arrow

N/A

-0.36
vs -0.26

Q2.23

arrow
arrow

N/A

-0.38
vs -0.30

Q3.23

arrow
arrow

N/A

-0.39
vs -0.30

Q4.23

arrow
arrow

N/A

-0.28
vs -0.28

Q1.24

arrow
arrow

N/A

-0.26
vs -0.36

Q2.24

arrow
arrow

N/A

-0.18
vs -0.38

Q3.24

arrow
arrow

N/A

-0.20
vs -0.39

Q4.24

arrow
arrow

N/A

-0.17
vs -0.28

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-22%

10.4M  vs 13.4M

Q4.22

arrow
arrow

-14%

15.3M  vs 17.7M

Q1.23

arrow
arrow

-19%

11.9M  vs 14.7M

Q2.23

arrow
arrow

+1%

12.9M  vs 12.7M

Q3.23

arrow
arrow

+5%

10.9M  vs 10.4M

Q4.23

arrow
arrow

-29%

10.9M  vs 15.3M

Q1.24

arrow
arrow

-14%

10.2M  vs 11.9M

Q2.24

arrow
arrow

-41%

7.6M  vs 12.9M

Q3.24

arrow
arrow

-22%

8.6M  vs 10.9M

Q4.24

arrow
arrow

+17%

12.8M  vs 10.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-24%

-0.24
vs -0.06

Q4.22

arrow
arrow

-7%

-0.07
vs -0.24

Q1.23

arrow
arrow

-10%

-0.10
vs -0.07

Q2.23

arrow
arrow

-12%

-0.12
vs -0.10

Q3.23

arrow
arrow

-13%

-0.13
vs -0.12

Q4.23

arrow
arrow

-14%

-0.14
vs -0.13

Q1.24

arrow
arrow

-11%

-0.11
vs -0.14

Q2.24

arrow
arrow

-10%

-0.10
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

184

184
vs 203

-9%

Q4.22

arrow
arrow

192

192
vs 184

4%

Q1.23

arrow
arrow

173

173
vs 192

-10%

Q2.23

arrow
arrow

162

162
vs 173

-6%

Q3.23

arrow
arrow

162

162
vs 162

NA

Q4.23

arrow
arrow

150

150
vs 162

-7%

Q1.24

arrow
arrow

151

151
vs 150

1%

Q2.24

arrow
arrow

144

144
vs 151

-5%

Earnings Growth

Latest News